2016 Analysis of Global Instrumentation Leading Enterprises

According to analysts, Thermo Fisher who had been forecasted by analysts to "return to buyers' identity" has already purchased Affymetrix and FEI this year. Through this, Thermo Fisher's market value has exceeded US$60 billion at one stroke, making it the most expensive company in the global instrument market. It really takes the name of "Macao". However, Thermo Fisher did not seem to meet this status. Recently, there are media reports that it has thrown an olive branch to Illumina and the offer price is US$30 billion. Although the rumors have not yet received an official response from Thermo Scientific, the industry can not help but speculate: After the whale swallowed Life Tech, whether or not the company can digest such a large-scale transaction.

Danaher, the instrument giant that has occupied the throne of NO.1 for many years in a row, has lost its market capitalization to less than US$60 billion with the dismantling and listing of Fortive, and has therefore fallen to second place in this company’s market capitalization ranking. Currently Danaher’s “splitting drama” has not yet come to an end. However, Fortive has already operated independently. It is believed that New Danaher, who has integrated PALL, will soon be “coming out”. The split does not affect acquisitions. Danaher, who is good at capital operations, is still on the avenue of mergers and acquisitions. Danaher, after the “downsizing,” will become better in terms of digestion and absorption.

As an upstream gene sequencing giant, Illumina is not only the "Chang'e" in the eyes of buyers, but also the "darling" of Wall Street investors. Illumina's market value has been rising year after year since it rejected the 6.7 billion U.S. dollar bid offer in 2012. At present, it ranks third with more than 25 billion U.S. dollars. Look at the difference between its market value and those of the previous and the next, and it has been determined that Illumina will remain in the third position for several years. Today, the world's "speculative" precision medicine, a large number of outstanding medical breakthroughs and financial investments have opened trillions of blue oceanic markets for gene sequencing technology. Since future growth is expected to expire, Illumina is likely to demand the acquisition of Thermo Fisheries once again Say. No!

Why optimistic expectations for Danaher's split integration? Agilent, now ranked fourth, is a good answer! The strategic focus of Agilent's separation has turned to life sciences and diagnostics. As mentioned above, this is a potential market with huge growth potential, and Agilent's measures such as the NMR business and the acquisition of Dako have also fully confirmed this strategy. Although still in fourth place, Agilent's "undervalued market value" is gradually returning, and there are reports that Agilent is still "ready to do" in terms of mergers and acquisitions. It is just around the corner to go beyond the $18.4 billion in market value before the split.

In the last inventory, Waters' market value was only one step away from 10 billion US dollars. Today, it is nearly 13 billion US dollars. At the same time, METTLER TOLEDO has reached the market value of 10 billion US dollars. The market value of the remaining four companies, Qiagen, PerkinElmer, Bio-Rad, and Bruck, is still below US$10 billion; it is worth mentioning that Brooke is the only instrument in which the market value of the two stocks declined. The company, therefore, ranks at the bottom of this ranking.

Continued mergers and acquisitions have created one after another giant instrument companies, of course, also let many instrument companies with potential to become giants disappear. After Life Tech, Sigma-Aldrich, Pall and other brands faded out of the rankings due to acquisitions, this year, FEI was removed from the TOP10 list due to the acquisition of Thermocraft.


Report details page: http://service.made-in-china.com/market-analysis/industry-analysis-report/688664.html
More reports: http://service.made-in-china.com/market-analysis/industry-analysis-report-1.html